Type 2 Diabetes

Researchers found that despite eligibility, few adults with type 2 diabetes use GLP-1 receptor agonists and SGLT-2 inhibitors. The study’s lead investigator Shichao Tang, PhD, answers questions about the...

In this video roundtable discussion, Carol Wysham, MD, interviews Eugene E. Wright, Jr., MD, and Hope Warshaw, MMSc, RD, CDCES, BC-ADM, about the multidisciplinary approach to managing people with...

In this podcast, Joëlle E. Vergroesen, MSc, discusses the results of her team's study examining how the use of metformin, insulin, and sulfonylurea derivatives may impact the risk of open-angle glaucoma,...

In their single-center study, Viral Shah, MD, and his research team analyzed the association between diabetes technology use and mean clinic hemoglobin A1C among adults with type 1 diabetes.

Gulsen Ozen, MD, answers questions about her team’s research in the use of statins to help reduce the risk of cardiovascular disease and type 2 diabetes in individuals with rheumatoid arthritis.

In this Q and A, Robin Gal, MSPH, CCRA, Grazia Aleppo, MD, FACE, FACP, and Teresa McArther, MS, RD, CDES answer questions about their study that investigated the use of a virtual clinic to support...

In this podcast, Caroline Trapp, DNP, ANP-BC, CDCES, talks about ways to achieve partial and full remission of type 2 diabetes and how certified diabetes care and education specialists can identify the type...

In this podcast, Livleen Gill, MBA, RDN, LDN, FAND, discusses creating a standardized care delivery system for older adults with type 2 diabetes in Maryland, connecting health care with community-based...